Collplant Holdings (CLGN) has released an update.
CollPlant Biotechnologies Ltd. announced that their shareholders approved all six proposals presented at the Annual and Extraordinary General Meeting on September 25, 2024. These proposals were detailed previously in the company’s Notice and Proxy Statement. This approval is a positive step for the company, reflecting shareholder confidence in the management’s strategy and direction.
For further insights into CLGN stock, check out TipRanks’ Stock Analysis page.
